当前位置: X-MOL 学术Cancer J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Critical Role of the Oncology Nurse as a Partner in the Management of Patients With Advanced Kidney Cancer: Toxicity Management, Symptom Control, and Palliative Care.
The Cancer Journal ( IF 2.2 ) Pub Date : 2020-09-01 , DOI: 10.1097/ppo.0000000000000476
Nancy P. Moldawer , Laura S. Wood

The treatment of advanced renal cell carcinoma has changed dramatically since 2005 with the approval of 12 regimens including oral, intravenous, and combination strategies. These approvals have changed the treatment paradigm for these patients and developed new challenges and a critical role for oncology nurses to ensure that the treatment plan and adverse events are managed effectively. The majority of these regimens include an oral anticancer drug, which requires patients and their caregivers to understand the medication, the potential adverse events, the importance of medicine adherence, and the importance of early and ongoing education with the oncology team to maximize clinical outcomes. The evolution of the role of the nurse in meeting this need and its critical contribution to the comprehensive care of the kidney cancer patient will be reviewed.



中文翻译:

肿瘤科护士作为合作伙伴在晚期肾癌患者管理中的关键作用:毒性管理、症状控制和姑息治疗。

自 2005 年以来,随着包括口服、静脉内和联合治疗在内的 12 种方案获得批准,晚期肾细胞癌的治疗发生了巨大变化。这些批准改变了这些患者的治疗模式,并为肿瘤科护士带来了新的挑战和关键作用,以确保有效管理治疗计划和不良事件。这些方案中的大多数包括口服抗癌药物,这要求患者及其护理人员了解药物、潜在的不良事件、药物依从性的重要性,以及与肿瘤学团队进行早期和持续教育以最大限度地提高临床结果的重要性。护士在满足这一需求方面角色的演变及其对全面护理的重要贡献肾癌患者将接受审查。

更新日期:2020-09-21
down
wechat
bug